Cited by 641Bacterial Identification and Susceptibility TestingClinical Laboratory Practices and Quality ControlSepsis Diagnosis and Treatment

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya

Open access
Miller, J Michael, Binnicker, Matthew J, Campbell, Sheldon, Carroll, Karen C, Chapin, Kimberle C, Gilligan, Peter H, Gonzalez, Mark D, Jerris, Robert C +12 more·2018·Clinical Infectious Diseases

Abstract

The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician/advanced practice provider and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. This document presents a system-based approach rather than specimen-based approach, and includes bloodstream and cardiovascular system infections, central nervous system infections, ocular infections, soft tissue infections of the head and neck, upper and lower respiratory infections, infections of the gastrointestinal tract, intra-abdominal infections, bone and joint infections, urinary tract infections, genital infections, and other skin and soft tissue infections; or into etiologic agent groups, including arthropod-borne infections, viral syndromes, and blood and tissue parasite infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. In addition, the pediatric needs of specimen management are also emphasized. There is intentional redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a guidance for physicians in choosing tests that will aid them to quickly and accurately diagnose infectious diseases in their patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciy381

Cites

277 of 277 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Current guidelines recommend targeted PCRs in specific situations rather than routine syndromic testing.

    “Current guidelines therefore recommend targeted PCRs in specific situations rather than routine syndromic testing (10–14).”

    From Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy (2026) · cites this paper as [11]

    In XIV. VIRAL SYNDROMES (page unavailable), the guide recommends testing for the most likely agents and says broad initial testing for numerous viruses is typically not cost-effective. The Stool Culture section also calls for selective use of multiplex tests. These passages support selective testing, but the guide does not make the claimed general recommendation to use targeted PCRs instead of routine syndromic testing across conditions; its Bronchitis and Bronchiolitis section notes that broad respiratory NAAT panels have largely replaced older tests in many institutions. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • In our cohort, a targeted PCR approach would have missed 10 (18%) bacterial meningitis cases caused by H. influenzae, S. agalactiae, and E. coli K1.

    “In our cohort, such an approach would have missed 10 (18%) bacterial meningitis cases caused by H. influenzae, S. agalactiae, and E. coli K1 (10–14).”

    From Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy (2026) · cites this paper as [11]

    Table 6 (Etiologic Agents; page unavailable) lists H. influenzae, S. agalactiae, and E. coli as bacterial meningitis agents. The guide does not evaluate the targeted PCR approach or establish which organisms it would miss. The 10 cases (18%) are presented as the citing authors’ own cohort result, not as a finding from this guide. (LLM, conf=0.79)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 9

  1. Baron EJ, Weinstein MP, Dunne WMJ, Yagupsky P, Welch DF, Wilson DM, eds. Cumitech 1C, Blood cultures IV. Washington, DC: ASM Press, 2005.
  2. Durland M. Periocular infection. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2005.
  3. Leibowitz HM. The red eye. N Engl J Med 2000; 343:345-51.
  4. Taylor HR, Burton MJ, Haddad D, West S, Wright H. Trachoma. Lancet 2014; 384:2142-52.
  5. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxo- plasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002; 109:869-78.
  6. Belmont MJ, Behar PM, Wax MK. Atypical presentations of actinomycosis. Head Neck 1999; 21:264-8.
  7. Klein JO, Bluestone CD. Otitis media. In: Cherry JD, Harrison GJ, Kaplan SL, Steinback WJ, Hotez PJ, eds. Feigin and Cherry's textbook of pediatric infectious diseases, 7th ed. Philadelphia: Saunders Elsevier, 2014:209-32.
  8. Cherry JD, Mundi J, Shapiro NL. Rhinosinusitis. In: Cherry JD, Harrison GJ, Kaplan SL, Steinback WJ, Hotez PJ, eds. Feigin and Cherry's textbook of pediatric infectious diseases, 7th ed. Philadelphia: Saunders Elsevier, 2014:193-203.
  9. McCarter YS, Burd EM, Hall GS, Zervos M, eds. Cumitech 2C: laboratory diagno- sis of urinary tract infections. Washington, DC: ASM Press, 2009. 185.

Cited by

Sorted by citations

Authors
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., Pritt, B. S., Richter, S. S., Robinson-Dunn, B., Schwartzman, J. D., Snyder, J. W., Telford, S., Theel, E. S., Thomson, R. B., Weinstein, M. P., & Yao, J. D.
Affiliations
  • Microbiology Technical Services, LLC, Dunwoody, Georgia
  • Mayo Clinic (US)
  • Yale University (US)
  • Johns Hopkins Medicine (US)
  • Rhode Island Hospital (US)
  • University of North Carolina at Chapel Hill (US)
  • Children's Healthcare of Atlanta (US)
  • Medical College of Wisconsin (US)
  • Cleveland Clinic (US)
  • Beaumont Health (US)
  • Dartmouth–Hitchcock Medical Center (US)
  • University of Louisville (US)
  • Tufts University (US)
  • Endeavor Health (US)
  • Rutgers, The State University of New Jersey (US)
Corresponding author
Miller, J Michael
Venue
Clinical Infectious Diseases
Published
2018-06-28
Volume
67
Issue
6
Pages
e1-e94
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W4211113261
Cited by
641
References
277
Citations by year
2026: 74 · 2025: 104 · 2024: 94 · 2023: 108 · 2022: 87 · 2021: 76 · 2020: 57 · 2019: 34 · 2018: 7
FWCI
33.75
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Infectious Diseases Society of America
  • Cleveland Clinic
  • Beaumont Health System
  • Dartmouth College
  • BioFire Diagnostics
  • Astellas Pharma
  • National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
Keywords
infectious disease diagnosis, diagnostic test selection, sample collection, sample transport, bloodstream infection, central nervous system infection, respiratory infections, urinary tract infection, bone and joint infections, skin and soft tissue infections, arthropod-borne diseases, viral syndrome, parasitic infection, turnaround time
MeSH terms
Communicable Disease Control, Communicable Diseases, Humans, Respiratory Tract Infections, Societies, Scientific, Specimen Handling, United States, Soft Tissue Infections, Clinical Laboratory Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review